The Generic Pharmaceutical Association (GPhA), the trade association representing generic drug makers in the United States, is holding its annual meeting this weekend in Phoenix. Unfortunately, I couldn’t attend. A number of interesting news reports are coming out of the meeting:
- Generic Biotech Bill Will Pass This Year, Hatch Says (Bloomberg)
- U.S Regulators Aim to Add Resources for Generic Drug Reviews (Bloomberg)
- Generics Industry Set For More Consolidation (MarketWatch)
- Generic Versions of Biotech Drugs in Focus (MarketWatch)
- Former FDA Commissioner McClellan Says Biogenerics Legislation Is On the Horizon (GPhA press release)
- GPhA Kicks Off Annual Meeting With Focus on Biogenerics Legislation (GPhA press release)
Orange Book Blog 
Leave a comment